Effect of transdermal testosterone replacement in hypogonadal men with decreased insulin sensitivity

Trial Profile

Effect of transdermal testosterone replacement in hypogonadal men with decreased insulin sensitivity

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Apr 2015

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism; Insulin resistance; Metabolic syndrome; Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic
  • Acronyms TIMES-2
  • Most Recent Events

    • 06 Jan 2012 Actual end date changed from Jun 2008 to Aug 2008 as reported by ISRCTN: Current Controlled Trials
    • 30 Mar 2011 Results have been published in Diabetes Care, according to a ProStrakan media release.
    • 18 Jun 2008 Testosterone gel is expected to be filed for approval in the US in the second half of 2008, according to a ProStrakan media release..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top